PreDxion Bio's technology, MicroKine™, is a novel, patent-pending near bedside diagnostic device that can identify up to six cytokine proteins (proteins that control and direct the body's response to inflammation) within just 30 minutes from a single drop of blood. Using this technology, physicians can tailor ICU treatment to a particular patient's needs -- thereby, bringing precision medicine to the ICU.  

With over 5 million admissions to the ICU every year in the U.S. alone, MicroKine has significant potential to change the system, save lives, and reduce healthcare costs.